Uncover key drivers, emerging technologies, and competitive movements shaping the intravenous (iv) compounding automation market from 2026–2035 with trusted insights from The Business Research Company
What growth pattern is forecast for the Intravenous (IV) Compounding Automation Market size between 2026 and 2035?
The intravenous (IV) compounding automation market has witnessed substantial growth in recent years. This market is expected to expand from $2.19 billion in 2025 to $2.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.9%. The past growth in this market can be attributed to several factors, including the increasing implementation of robotic compounding systems, a rising need for chemotherapy automation, a greater emphasis on medication safety, the expansion of automation in hospitals and pharmacies, and growing recognition of workflow efficiency.
The intravenous (IV) compounding automation market is anticipated to experience substantial expansion in the coming years. The market is projected to expand to $3.79 billion in 2030, progressing at a compound annual growth rate (CAGR) of 11.6%. This growth throughout the forecast period stems from factors such as increasing investments in AI-enabled compounding solutions, the rising implementation of automated IV workstations, improved integration of software with hospital information systems, the expansion of remote monitoring and predictive maintenance capabilities, and the growing development of modular and customizable compounding systems. Significant trends anticipated in this period include innovations in AI and machine learning for compounding, advancements in robotic and automated devices, the evolution of smart pump and monitoring technologies, breakthroughs in sterile compounding isolators and safety cabinets, and progress in compact and space-saving automation solutions.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30629&type=smp
Which Drivers Are Impacting Market Performance In The Intravenous (IV) Compounding Automation Market?
The increasing need for pharmaceutical products is anticipated to fuel the expansion of the intravenous (IV) compounding automation market in the future. A pharmaceutical product refers to a compound or mixture of compounds designed for the diagnosis, treatment, prevention, or relief of illnesses and medical conditions in humans or animals. IV compounding automation assists in the production of pharmaceutical products by facilitating the accurate, secure, and streamlined preparation of intricate intravenous medications, thereby ensuring precise dosages, minimizing contamination hazards, and enabling healthcare providers to satisfy the rising requirement for superior therapies. For example, in November 2023, data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association, revealed that the overall pharmaceutical output in Europe reached €390,000 million ($422,803 million) in 2023, showing an increase from €363,300 million ($393,857 million) in 2022. Consequently, the escalating demand for pharmaceutical products is propelling the growth of the intravenous (IV) compounding automation market.
Which Segments Are Contributing To The Growth Of The Intravenous (IV) Compounding Automation Market?
The intravenous (iv) compounding automation market covered in this report is segmented –
1) By Product Type: Robotic Compounding Systems, Automated Compounding Devices, Software Solutions, Other Product Types
2) By Service: Installation, Maintenance, Training, Consulting, Support, System Integration, Validation, Software Updates, Calibration, Remote Monitoring
3) By Application: Chemotherapy, Parenteral Nutrition, Antibiotics, Other Applications
4) By End-User: Hospitals, Compounding Pharmacies, Oncology Centers, Other End-Users
Subsegments:
1) By Robotic Compounding Systems: Robotic Arm Based Systems, Closed System Robotic Compounding Units, Hazardous Drug Handling Robots, Sterile Preparation Robotic Platforms
2) By Automated Compounding Devices: Volumetric Compounding Devices, Gravimetric Compounding Devices, Multi Chamber Compounding Units, Automated Parenteral Nutrition Compounding Devices
3) By Software Solutions: Compounding Workflow Management Software, Dose Verification Software, Barcode Based Medication Safety Software, Compounding Data Analytics And Reporting Software
4) By Other Product Types: Semi Automated Compounding Systems, Isolator Based Compounding Systems, Sterile Admixture Preparation Cabinets, Hybrid Compounding Assistance Devices
Who Are The Top-Performing Companies In The Intravenous (IV) Compounding Automation Market In Recent Years?
Major companies operating in the intravenous (iv) compounding automation market are Becton Dickinson and Company, Baxter International Inc., Grifols S.A., ICU Medical Inc., Omnicell Inc., Fresenius Kabi AG, Equashield Medical Ltd., Health Robotics S.r.l., Loccioni Group, Loccioni Group, OPTIMA pharma GmbH, Medimix Systems AG, ARxIUM Inc., General Healthy Co. Ltd., PharmaScope Onco Automation B.V., Comecer SpA, Syntegon Technology GmbH, Parata Pharmacy Automation, B. Braun SE, Aesynt Incorporated, Shenzhen Broadcare Robots Co. Ltd.
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Intravenous (IV) Compounding Automation Market?
North America was the largest region in the intravenous (IV) compounding automation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) compounding automation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Intravenous (IV) Compounding Automation Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=30629&type=smp
Browse Through More Reports Similar to the Global Intravenous (IV) Compounding Automation Market 2026, By The Business Research Company
Automated Compounding Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report
Intravenous Solutions Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report
lab automation in drug discovery global market report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model